Evidence map›Paper›PMID 34458567›Full record

ArticleJournal of patient experience2021

Patient-Reported Communication With Their Health Care Team About New Treatment Options for Chronic Lymphocytic Leukemia.

Elissa C Kranzler, Julie S Olson, Helen M Nichols, Eva Yn Yuen, Shauna McManus, Joanne S Buzaglo, Alexandra K Zaleta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of patient experience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elissa C KranzlerCancer Support Community, Research and Training Institute, Philadelphia, PA, USA.
Julie S OlsonCancer Support Community, Research and Training Institute, Philadelphia, PA, USA.
Helen M NicholsCancer Support Community, Washington, DC, USA.
Eva Yn YuenDeakin University, Centre for Quality and Patient Safety Research, Institute for Health Transformation, Burwood, VIC, Australia.
Shauna McManusCancer Support Community, Research and Training Institute, Philadelphia, PA, USA.
Joanne S BuzagloConcertAI, Boston, MA, USA.
Alexandra K ZaletaCancer Support Community, Research and Training Institute, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-8589-4722

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) often requires consideration of multiple treatment options. Shared decision-making (SDM) is important, given the availability of increasingly novel therapies; however, patient-provider treatment conversations vary. We examined relationships between patient-provider discussions of new CLL treatment options and sociodemographic, clinical, and patient-provider communication variables among 187 CLL patients enrolled in Cancer Support Community's Cancer Experience Registry. Factors significantly associated with self-reports of whether patients' providers discussed new CLL treatment options with them were examined using χ

Indexed as

chronic lymphocytic leukemiapatient educationpatient–provider communicationshared decision-making

Identifiers

PMID34458567
PMCPMC8392805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.